Condition
Hyperglycemia Steroid-induced
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
Early P 1 (1)
P 4 (3)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07573930Recruiting
Metabolic Control in Anesthesia and Surgery
NCT03661684Early Phase 1Completed
Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2
NCT03511521Phase 4TerminatedPrimary
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
NCT04021186Not ApplicableUnknownPrimary
An Optimization in the Postoperative Treatment in Head and Neck--surgical Patients.
NCT02253121Phase 4CompletedPrimary
Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02155374Phase 4CompletedPrimary
Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy
Showing all 6 trials